RADNET INC (RDNT) Stock Fundamental Analysis
NASDAQ:RDNT - Nasdaq - US7504911022 - Common Stock - Currency: USD
Taking everything into account, RDNT scores 4 out of 10 in our fundamental rating. RDNT was compared to 102 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of RDNT get a neutral evaluation. Nothing too spectacular is happening here. RDNT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year RDNT was profitable.
In the past year RDNT had a positive cash flow from operations.
RDNT had positive earnings in 4 of the past 5 years.
In the past 5 years RDNT always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of RDNT (-0.97%) is comparable to the rest of the industry.
RDNT has a Return On Equity of -3.60%. This is comparable to the rest of the industry: RDNT outperforms 49.02% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.38%, RDNT is in line with its industry, outperforming 45.10% of the companies in the same industry.
RDNT had an Average Return On Invested Capital over the past 3 years of 2.96%. This is significantly below the industry average of 9.62%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -3.6% | ||
| ROIC | 2.38% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
1.3 Margins
In the last couple of years the Profit Margin of RDNT has declined.
RDNT has a Operating Margin (4.38%) which is in line with its industry peers.
RDNT's Operating Margin has been stable in the last couple of years.
The Gross Margin of RDNT (22.61%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of RDNT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.38% | ||
| PM (TTM) | N/A | ||
| GM | 22.61% |
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
RDNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
RDNT has about the same amout of shares outstanding than it did 1 year ago.
RDNT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for RDNT is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.80, we must say that RDNT is in the distress zone and has some risk of bankruptcy.
RDNT's Altman-Z score of 1.80 is in line compared to the rest of the industry. RDNT outperforms 44.12% of its industry peers.
The Debt to FCF ratio of RDNT is 12.96, which is on the high side as it means it would take RDNT, 12.96 years of fcf income to pay off all of its debts.
RDNT's Debt to FCF ratio of 12.96 is in line compared to the rest of the industry. RDNT outperforms 43.14% of its industry peers.
A Debt/Equity ratio of 1.10 is on the high side and indicates that RDNT has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.10, RDNT is doing worse than 64.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | 12.96 | ||
| Altman-Z | 1.8 |
ROIC/WACC0.27
WACC8.78%
2.3 Liquidity
RDNT has a Current Ratio of 2.01. This indicates that RDNT is financially healthy and has no problem in meeting its short term obligations.
RDNT has a Current ratio of 2.01. This is in the better half of the industry: RDNT outperforms 74.51% of its industry peers.
A Quick Ratio of 2.01 indicates that RDNT has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.01, RDNT is doing good in the industry, outperforming 77.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 2.01 |
3. Growth
3.1 Past
RDNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.69%.
RDNT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.79% yearly.
The Revenue has grown by 12.76% in the past year. This is quite good.
The Revenue has been growing by 9.65% on average over the past years. This is quite good.
EPS 1Y (TTM)-67.69%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%-600%
Revenue 1Y (TTM)12.76%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%9.19%
3.2 Future
The Earnings Per Share is expected to grow by 6.20% on average over the next years.
The Revenue is expected to grow by 8.17% on average over the next years. This is quite good.
EPS Next Y-48.3%
EPS Next 2Y6.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.15%
Revenue Next 2Y8.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 263.86, which means the current valuation is very expensive for RDNT.
61.76% of the companies in the same industry are cheaper than RDNT, based on the Price/Earnings ratio.
RDNT is valuated expensively when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 77.98, which means the current valuation is very expensive for RDNT.
61.76% of the companies in the same industry are cheaper than RDNT, based on the Price/Forward Earnings ratio.
RDNT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 263.86 | ||
| Fwd PE | 77.98 |
4.2 Price Multiples
RDNT's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as RDNT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.35 | ||
| EV/EBITDA | 15.71 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)15.72
EPS Next 2Y6.2%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for RDNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
55.41
-1.17 (-2.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.09%
Inst Owner Change9.55%
Ins Owners13.48%
Ins Owner Change0.04%
Market Cap4.16B
Analysts86.67
Price Target73.44 (32.54%)
Short Float %10.47%
Short Ratio8.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-77.8%
Min EPS beat(2)-161.6%
Max EPS beat(2)5.99%
EPS beat(4)2
Avg EPS beat(4)-35.08%
Min EPS beat(4)-161.6%
Max EPS beat(4)20.87%
EPS beat(8)6
Avg EPS beat(8)178.25%
EPS beat(12)7
Avg EPS beat(12)117.98%
EPS beat(16)9
Avg EPS beat(16)-190%
Revenue beat(2)2
Avg Revenue beat(2)2.78%
Min Revenue beat(2)1.29%
Max Revenue beat(2)4.27%
Revenue beat(4)4
Avg Revenue beat(4)2.9%
Min Revenue beat(4)1.29%
Max Revenue beat(4)4.27%
Revenue beat(8)8
Avg Revenue beat(8)1.8%
Revenue beat(12)10
Avg Revenue beat(12)1.98%
Revenue beat(16)12
Avg Revenue beat(16)0.96%
PT rev (1m)0.47%
PT rev (3m)-13.6%
EPS NQ rev (1m)0.44%
EPS NQ rev (3m)-18.09%
EPS NY rev (1m)0%
EPS NY rev (3m)-50.77%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)0.25%
Revenue NY rev (1m)0.75%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 263.86 | ||
| Fwd PE | 77.98 | ||
| P/S | 2.22 | ||
| P/FCF | 53.35 | ||
| P/OCF | 16.15 | ||
| P/B | 4.63 | ||
| P/tB | 41.19 | ||
| EV/EBITDA | 15.71 |
EPS(TTM)0.21
EY0.38%
EPS(NY)0.71
Fwd EY1.28%
FCF(TTM)1.04
FCFY1.87%
OCF(TTM)3.43
OCFY6.19%
SpS24.91
BVpS11.97
TBVpS1.35
PEG (NY)N/A
PEG (5Y)15.72
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -3.6% | ||
| ROCE | 2.9% | ||
| ROIC | 2.38% | ||
| ROICexc | 3.19% | ||
| ROICexgc | 5.13% | ||
| OM | 4.38% | ||
| PM (TTM) | N/A | ||
| GM | 22.61% | ||
| FCFM | 4.17% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
ROICexc(3y)3.61%
ROICexc(5y)3.42%
ROICexgc(3y)6.03%
ROICexgc(5y)5.63%
ROCE(3y)3.6%
ROCE(5y)3.56%
ROICexcg growth 3Y-3.51%
ROICexcg growth 5Y-1.27%
ROICexc growth 3Y-4.28%
ROICexc growth 5Y-1.4%
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | 12.96 | ||
| Debt/EBITDA | 3.48 | ||
| Cap/Depr | 89.2% | ||
| Cap/Sales | 9.6% | ||
| Interest Coverage | 0.97 | ||
| Cash Conversion | 90.9% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.01 | ||
| Quick Ratio | 2.01 | ||
| Altman-Z | 1.8 |
F-Score5
WACC8.78%
ROIC/WACC0.27
Cap/Depr(3y)97.03%
Cap/Depr(5y)109.5%
Cap/Sales(3y)9.85%
Cap/Sales(5y)9.84%
Profit Quality(3y)1105%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.69%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%-600%
EPS Next Y-48.3%
EPS Next 2Y6.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.76%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%9.19%
Revenue Next Year8.15%
Revenue Next 2Y8.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.09%
EBIT growth 3Y5.38%
EBIT growth 5Y8.53%
EBIT Next Year110.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.28%
FCF growth 3Y90.52%
FCF growth 5Y8.35%
OCF growth 1Y44.54%
OCF growth 3Y15.95%
OCF growth 5Y17.44%